Sponsored Lunch Symposia


Thursday, 22 March 2018

Company : Roche Diagnostics International Ltd
Time 12:50 – 14:20
Hall 406CX, Level 4
Title Cell-Free DNA Testing in Clinical Practice Today
Chairperson Prof Maximilian Schmid, USA
    MD. Senior Director Medical Affairs, Roche Diagnostics - San Jose, CA, USA
Time Topic Speaker
12:50 – 13:05 Introduction and lunch distribution  
13:05 – 13:35 Cell-Free DNA Testing for Fetal Aneuploidy – Overview of Scientific Evidence and Clinical Implementation Models

Dr Maria Del Mar Gil, Spain

MD, PhD
Torrejón University Hospital
Madrid

13:35 – 14:05 Clinical and Laboratory Implementation of Cell-Free DNA Testing - Lessons Learned and Implications for Clinicians

Prof George Yeo, Singapore

MBBS, FRCOG, FAMS
KK Women's and Children's Hospital 

14:05 – 14:20 Conclusion and Collection of Lunchboxes  

Thursday, 22 March 2018

Company : Merck Pte Ltd
Time 12:50 – 14:20
Hall 405B, Level 4
Title Anemia During Pregnancy and Beyond: Truth, Myths & The Unknown
Chairperson Dr Lee Keen Whye, Singapore
    Consultant, Obstetrician and Gynaecologist in private practice at Gleneagles Medical Centre
Time Topic Speaker
12:50 -13:05 Introduction and Lunch Distribution  
13:05 – 14:05 Impact of Iron Deficiency on Foetal Development, Birth Outcomes and Infant Development Dr Michael Low
Challenges for The Prevention and Treatment of IDA before/during Pregnancy in Asia Dr Rajapriya
14:05 – 14:20 Conclusion and Collection of Lunchboxes  

Friday, 23 March 2018

Company : Ferring Pharmaceuticals
Time 12:40 – 14:10
Hall 406CX, Level 4
Title What’s New in PPH Prevention?
Chairperson Prof Sabaratnam Arulkumaran, UK
  Prof Su Lin Lin, Singapore
Time Topic Speaker
12:40 – 12:55 Lunch Distribution  
12:55 – 13:00 Opening Speech Prof Sabaratnam Arulkumaran, UK
13:00 – 13:20

Which Uterotonics Work The Best?

A Cochrane Review Update
Prof Su Lin Lin, Singapore
13:20 – 13:40

Uterotonics for the Prevention of PPH: Haemodynamic Considerations

Prof Leiv Arne Rosseland, Norway
13:40 – 14:00 Imox: Comparative Clinical Trial in the UK Setting Prof Tim Draycott, UK
14:00 Closing Speech Prof Su Lin Lin, Singapore

Friday, 23 March 2018

Company : Vifor Pharma
Time 12:40 – 14:10
Hall 406D, Level 4
Title Managing Blood Loss in Women: Can We Do More?
Chairperson Dr Diana Mansour, UK
Time Topic Speaker
12:40 – 12:55 Lunch Distribution  
13:05 – 14:10 Welcome and Introduction Dr Diana Mansour, UK
Put in the Plug, Turn off the Tap: Solutions for Gynaecological Surgery Prof Jason Abbott, Australia
Peri-Partum Bleeding – An Update on Treatment Approaches to Optimise Outcomes Prof Irene Hösli, Switzerland
Preparing at Risk Patients for High Blood Loss Surgeries Dr Hairil Rizal bin Abdullah, Singapore
Qestion & Answer  

Friday, 23 March 2018

Company Bayer (South East Asia) Pte Ltd 
Time 12:40 – 14:10 
Hall 404A, Level 4
Title Real World Evidence in Contraception 
Chairperson Prof Delfin Tan, Phillipines
   Head, Section of Reproductive Endocrinology and InfertilitySection of the Department of Obstetrics and Gynecology, St. Luke’s Medical Center, Quezon City 
Time Content Speaker
12:40 – 12:55 Lunch Distribution  
12:55 – 13:00 Introduction of the Session  Prof Delfin Tan, Philippines
13:00 – 13:10 Overview of Contraception in Asia
13:10 – 13:50 Real World Evidence in Contraception, including Sexuality while Taking Hormonal Contraception Prof Rossella E. Nappi, Italy
13:50 – 14:10 Question & Answer

 

Friday, 23 March 2018

Company : Roche Diagnostics International Ltd
Time 12:40 – 14:10
Hall 405B, Level 4
Title The sFlt-1/PlGF ratio: A Novel Tool in the Management of Women with Suspected Preeclampsia
Chairperson Prof Maximilian Schmid, USA
  MD. Senior Director Medical Affairs, Roche Diagnostics - San Jose, CA, USA
Time Topic Speaker
12:40 – 12:55 Introduction and Lunch Distribution  
12:55 – 13:25 PROGNOSIS Asia: Prediction of Short-Term Outcome in Pregnant Women with Suspected Preeclampsia using the sFlt-1/PlGF Ratio Prof Tan Kok Hian, Singapore
MBBS, MMed
KK Women's and Children's Hospital
13:25 – 13:55 The sFlt-1/PlGF Ratio: From Evidence to Clinical Use Prof Holger Stepan, Germany
M.D.
Head, Department of Obstetrics.
Leipzig University
13:55 – 14:10 Conclusion and Collection of Lunchboxes  

Saturday, 24 March 2018

Company: Obstetrical & Gynaecological Society of Singapore (OGSS)

Time13:00 – 14:30

Hall: 406CX, Level 4

Title: Maternal Immunisation

Chairperson: Dr Tony Tan, Singapore

Time Topic Speaker
13:00 – 13:20 Introduction and Lunch Distribution  
13:20 – 13:35 Why Immunize Pregnant Women against Pertussis and Influenza? Dr Leong Hoe Nam, Singapore
13:35 – 13:50 Maternal Vaccination in Australia – Strategies to Improve Uptake Rates Prof Terry Nolan, Australia
13:50 – 14:05 Safety of Tdap and Influenza Vaccines in Pregnancy Dr Helen Petousis, New Zealand
14:05 Q & A